stock price decline

Rosen Law Firm launches securities investigation into $PFSI after January earnings report triggered 33% stock collapse, alleging materially misleading disclosures.

Class action lawsuit filed against $TCOM over alleged concealment of Chinese regulatory investigation into monopolistic practices. Stock plunged 17.05% following disclosure.

NuScale Power faces securities fraud lawsuit over $495M deal with inexperienced partner ENTRA1 Energy; stock fell 12.4% after disclosure.

Federal securities lawsuit filed against Camping World Holdings for allegedly overstating inventory capabilities. Stock dropped 24.8% and 16.5% in Q3-Q4 2025; investors have until May 11, 2026 to join.

Gossamer Bio ($GOSS) faces class action lawsuit over failed PROSERA PAH trial; stock crashed 80% to $0.42 per share on February 23, 2026, amid allegations of misleading investor statements.

The Portnoy Law Firm investigates $ICHR following a 23.2% stock collapse tied to Q1 2025 earnings miss and margin compression.

Girard Sharp LLP investigates potential securities violations in Compass's January 2026 Anywhere Real Estate acquisition, citing significant post-merger stock decline.

Ultragenyx faces securities fraud lawsuit after setrusumab Phase 3 failure triggered 42% stock decline. Lead plaintiff applications due April 6, 2026.

Law firm launches class action against $KYD over alleged securities fraud, citing missed filings, control weaknesses, and executive departures following stock plunge.

Gartner faces securities class action after stock plunged 48% due to undisclosed contract value growth deterioration. Investors have until May 18, 2026, to file claims.

Class action lawsuit filed against $SMCI following DOJ indictment for illegally diverting $2.5B in AI servers to China, triggering 33.3% stock decline.

TruBridge disclosed accounting errors preventing timely 2025 Annual Report filing, triggering 10.5% stock decline and securities investigation by Kirby McInerney LLP.

Hagens Berman sues Gemini Space Station over alleged IPO fraud. Stock plunged 75% following undisclosed pivot to prediction markets and executive exodus.

ImmunityBio ($IBRX) shares plunged 21% after FDA warning over false Anktiva efficacy claims, erasing $2 billion in market value and triggering securities litigation.

PayPal faces securities class action lawsuit following CEO exit and $10 billion shareholder loss after withdrawing 2027 guidance, alleging management misled investors on key metrics.

Pomerantz Law Firm investigates $EVTL for potential securities fraud following going concern disclosure that sparked 18.18% stock decline.

$YRD plummets 45% following Q4 revenue collapse to RMB 957.6M, far below RMB 1.4-1.6B guidance, triggering Pomerantz Law Firm investigation.

Pomerantz LLP investigates Banco Santander for potential securities fraud over undisclosed exposure to collapsed UK mortgage lender. $SAN shares fell 7.57% to $11.96 on February 28, 2026.

Driven Brands faces class action lawsuit over material accounting restatements spanning 2023-2025. Stock fell 30.16%; investors must join suit by May 11, 2026.

Pomerantz LLP files securities fraud class action against Camping World Holdings ($CWH) following disclosure of declining revenues, margin compression, and dividend suspension. Investors must act by May 11, 2026.